Literature DB >> 14602675

Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy.

H J Mason1, J Morton, S J Garfitt, S Iqbal, K Jones.   

Abstract

We recently carried out a study of two UK hospital pharmacy units preparing cytotoxic drugs using isolators that showed low level contamination on floor surfaces and disposable gloves worn by staff. It has been suggested that this level of contamination may be related to some level of contamination on the drug vials as delivered from manufacturers rather than leakage from the isolators. We have investigated the level of cytotoxic drug contamination on the external surfaces of the drug vials as delivered to a hospital pharmacy stores. We monitored 30, randomly chosen vials for the drugs cisplatin, carboplatin, cyclophosphamide, ifosfamide and methotrexate using well-established methods. A 0.5 m2 floor area directly in front of the shelves used for storing the cytotoxic drugs was also wipe sampled and the disposable gloves worn while wiping the vials for each drug were also analysed. A significant number of vials had a quantifiable level of external contamination. Levels of contamination up to 344 ng/vial were found. Levels of glove and floor contamination for some drugs were found to be comparable with values found in our study of the clean rooms where the isolators were situated and the pharmacy staff prepared the cytotoxic drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14602675     DOI: 10.1093/annhyg/meg078

Source DB:  PubMed          Journal:  Ann Occup Hyg        ISSN: 0003-4878


  15 in total

Review 1.  World at work: hospital pharmacy clean-rooms.

Authors:  C A Jackson; D A Wilson
Journal:  Occup Environ Med       Date:  2006-01       Impact factor: 4.402

2.  Hazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing process.

Authors:  Luci A Power; Paul J M Sessink; Kathy Gesy; Flay Charbonneau
Journal:  Hosp Pharm       Date:  2014-04

3.  Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals.

Authors:  Susana Viegas; Mário Pádua; Ana Costa Veiga; Elisabete Carolino; Mário Gomes
Journal:  Environ Monit Assess       Date:  2014-08-06       Impact factor: 2.513

4.  Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities.

Authors:  Wouter Fransman; Roel Vermeulen; Hans Kromhout
Journal:  Int Arch Occup Environ Health       Date:  2005-05-11       Impact factor: 3.015

5.  Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.

Authors:  M Hedmer; H Tinnerberg; A Axmon; B A G Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2007-12-08       Impact factor: 3.015

6.  Work-related leukemia: a systematic review.

Authors:  Ioannis Polychronakis; George Dounias; Vasilios Makropoulos; Elena Riza; Athena Linos
Journal:  J Occup Med Toxicol       Date:  2013-05-22       Impact factor: 2.646

7.  Evaluation of surface contamination with cyclophosphamide following simulated hazardous drug preparation activities using two closed-system products.

Authors:  Matthew D Zock; Scott Soefje; Keith Rickabaugh
Journal:  J Oncol Pharm Pract       Date:  2010-06-28       Impact factor: 1.809

8.  Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry.

Authors:  E E M Brouwers; A D R Huitema; E N Bakker; J W Douma; K J M Schimmel; G van Weringh; P J de Wolf; J H M Schellens; J H Beijnen
Journal:  Int Arch Occup Environ Health       Date:  2007-03-22       Impact factor: 3.015

9.  Occupational Exposure to Antineoplastic Drugs: Identification of Job Categories Potentially Exposed throughout the Hospital Medication System.

Authors:  Chun-Yip Hon; Kay Teschke; Prescillia Chua; Scott Venners; Lynne Nakashima
Journal:  Saf Health Work       Date:  2011-09-30

Review 10.  Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.

Authors:  Kurinchi Selvan Gurusamy; Lawrence Mj Best; Cynthia Tanguay; Elaine Lennan; Mika Korva; Jean-François Bussières
Journal:  Cochrane Database Syst Rev       Date:  2018-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.